Role of gut microbes in acute lung injury/acute respiratory distress syndrome
- PMID: 39658851
- PMCID: PMC11639474
- DOI: 10.1080/19490976.2024.2440125
Role of gut microbes in acute lung injury/acute respiratory distress syndrome
Abstract
Acute lung injury (ALI) is an acute, diffuse inflammatory lung condition triggered by factors of severe infections, trauma, shock, burns, ischemia-reperfusion, and mechanical ventilation. It is primarily characterized by refractory hypoxemia and respiratory distress. The more severe form, acute respiratory distress syndrome (ARDS), can progress to multi-organ failure and has a high mortality rate. Despite extensive research, the exact pathogenesis of ALI and ARDS remains complex and not fully understood. Recent advancements in studying the gut microecology of patients have revealed the critical role that gut microbes play in ALI/ARDS onset and progression. While the exact mechanisms are still under investigation, evidence increasingly points to the influence of gut microbes and their metabolites on ALI/ARDS. This review aims to summarize the role of gut microbes and their metabolites in ALI/ARDS caused by various triggers. Moreover, it explores potential mechanisms and discusses how gut microbe-targeting interventions might offer new clinical strategies for the treatment of ALI/ARDS.
Keywords: Gut microbe; acute lung injury; acute respiratory distress syndrome; gut–lung axis.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Macrophage pyroptosis and its crucial role in ALI/ARDS.Front Immunol. 2025 Feb 14;16:1530849. doi: 10.3389/fimmu.2025.1530849. eCollection 2025. Front Immunol. 2025. PMID: 40028334 Free PMC article. Review.
-
MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome.Int J Mol Sci. 2022 May 16;23(10):5545. doi: 10.3390/ijms23105545. Int J Mol Sci. 2022. PMID: 35628354 Free PMC article. Review.
-
Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome.Respir Res. 2021 Jan 6;22(1):1. doi: 10.1186/s12931-020-01578-8. Respir Res. 2021. Retraction in: Respir Res. 2022 Jun 25;23(1):170. doi: 10.1186/s12931-022-02066-x. PMID: 33407436 Free PMC article. Retracted.
-
Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS.Biomed Pharmacother. 2024 Jun;175:116773. doi: 10.1016/j.biopha.2024.116773. Epub 2024 May 21. Biomed Pharmacother. 2024. PMID: 38776679 Review.
-
Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome.J Control Release. 2023 Aug;360:1-14. doi: 10.1016/j.jconrel.2023.06.018. Epub 2023 Jun 19. J Control Release. 2023. PMID: 37330013 Review.
Cited by
-
Exploring the role of xanthine oxidase and aldehyde oxidase in metabolic dysfunction-associated steatotic liver disease (MASLD).J Mol Histol. 2025 Jul 23;56(4):237. doi: 10.1007/s10735-025-10507-2. J Mol Histol. 2025. PMID: 40699438 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources